Search

everythinglearnresearchcommunity

for

Search:↓

The 0.25% finasteride solution, when applied once a day, effectively reduces scalp DHT, potentially minimizing sexual side-effects linked to a systemic DHT reduction.

A vaccine may prevent benign prostatic hyperplasia (BPH).

Early-stage male pattern baldness shows two types of hair loss: one on the top of the head linked to hormonal changes, and another at the back of the head. The top hair loss responds well to specific treatment, while the back hair loss does not.

Women with hair thinning have disrupted steroid hormone levels, but this doesn't often show as other health issues. More research is needed on hormone balance in this condition.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Topical finasteride is promising for hair loss with minimal side effects but needs more research and approval.

The Cyp11a1 gene variation has a weak link to PCOS, but higher di-hydro-testosterone levels are found in PCOS patients.

Testosterone levels aren't important for depression in men, but some other hormones might affect certain symptoms.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

A woman's excessive hair growth was linked to a rare case of high testosterone caused by a prolactin-producing pituitary tumor.

Testosterone undecanoate can reduce the negative effects of Finasteride on male reproductive health.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

Finasteride reduces DHT to treat prostate issues and hair loss.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

5 alpha-reductase inhibitors, like finasteride, are used to treat conditions like prostate issues and skin disorders.

A new gene, JMJD1C, may affect testosterone levels in men.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

5α-reductases increase epitestosterone's effect on androgen receptors.

Finasteride may help reduce male hair loss and excessive hair growth by lowering DHT levels.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

Nanocarriers could improve minoxidil delivery for better hair loss treatment.

Nanocarrier systems could improve hair loss treatments by delivering drugs more effectively.

5α-reductase enzyme affects hormone levels, influencing conditions like acne and hair loss.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.